Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Amantadine: Mechanism of action of Amantadine. Blocks viral penetration/uncoating; may buffer pH of endosome. Also causes the release of dopamine from intact nerve terminals. "Amantadine blocks influenza A and rubellA and causes problems with the cerebellA." Amantadine: Clinical uses of Amantadine. Prophylaxis for influenza A; Parkinson's disease. Amantadine: Symptoms of Amantadine toxicity. Ataxia, dizziness, slurred speech. (Rimantidine is a derivative with fewer CNS side effects.) Zanamivir: Mechanism of action of Zanamivir. Inhibits influenza neuraminidase. Zanamivir: Clinical use of Zanamivir. Both influenza A and B. Ribavirin: Mechanism of action of Ribavirin. Inhibits synthesis of guanine nucleotides by competitively inhibiting IMP dehydrogenase. Ribavirin: Clinical use of Ribavirin. RSV (respiratory syncytial virus). Ribavirin: Symptoms of Ribavirin toxicity. Hemolytic anemia. Severe teratogen. Acyclovir: Mechanism of aciton of Acyclovir. Perferentially inhibits viral DNA polymerase when phosphorylated by viral thymidine kinase. Acyclovir: Clinical use of Acyclovir. HSV, VZV, EBV. Mucocutaneous and genital herpes lesions. Prophylaxis in immunocompromised patients. Acyclovir: Symptoms of Acyclovir toxicity. Delirium, tremor, nephrotoxicity. Ganciclovir (DHPG dihydroxy-2-propoxymethyl guanine): Mechanism of action of Ganciclovir. Phosphorlation by viral kinase; perferentially inhibits CMV DNA polymerase. Ganciclovir (DHPG dihydroxy-2-propoxymethyl guanine): Clinical use of Ganciclovir. CMV, especially in immunocompromised patients. Ganciclovir (DHPG dihydroxy-2-propoxymethyl guanine): Symptoms of Ganciclovir toxicity. Leukopenia, neutropenia, thrombocytopenia, renal toxicity. More toxic to host enzymes than acyclovir. Foscarnet: Mechanism of action of Foscarnet. Viral DNA polymerase inhibitor that binds to the pyrophophate binding site of the enzyme. Does not require activation by viral kinase. "FOScarnet = pyroFOSphate analog." Foscarnet: Clinical use of Foscarnet. CMV retinitis in immunocompromised patients when ganciclovir fails. Foscarnet: Symptoms of Foscarnet toxicity. Nephrotoxicity. HIV therapy: Saquinavir, ritonavir, indinavir, nelfinavir, amprenavir are example of this type of anti-HIV drug. Protease inhibitor. HIV therapy: Mechanism of action of protease inhibitors. Inhibit assembly of new virus by blocking protease enzyme. HIV therapy: Symptoms of protease inhibitor toxicity. GI intolerance (nausea, diarrhea), hyperglycemia, lipid abnormalities, thrombocytopenia (indinavir).